Company
RNATIVES
Developing precision RNA-based gene regulating therapies to treat serious diseases
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- rnatives.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Revolutionizing disease management with a unique microRNA platform and AI-driven precision.
Funding snapshot
- Latest round
- Seed2025-05-27
Funding rounds
- Seed
- 2025-05-27
Loading relationship preview